Kaiser Permanente Center for Health Research

Predicting Self-Harm Events After Emergency Department Visits Associated With Mental or Substance Use Disorder Diagnoses

OBJECTIVE: Using a machine learning model, the authors aimed to predict self-harm events within 90 days of an emergency department (ED) visit associated with a mental or substance use disorder diagnosis. METHODS: Electronic health record and claims data of patients ages ≥11 years...

Patient Characteristics and Outcomes Associated With Home‐Based Cardiac Rehabilitation

Background Referrals to and participation in cardiac rehabilitation programs remain suboptimal. We examined factors associated with home‐based cardiac rehabilitation (HBCR) referral and participation and associations of referral and participation with outcomes. Methods In this re...

Nicotine replacement therapy sampling for cigarette cessation in dental care: A National Dental Practice‐Based Research Network cluster randomized clinical trial

BACKGROUND AND AIMS: Cigarette smoking is detrimental to oral health. Oral health professionals rarely prescribe smoking cessation medications. Nicotine replacement therapy sampling (NRTS), providing brief starter courses of NRT, could improve provision of NRT and promote cessati...

Mifepristone versus other interventions for the prevention of pregnancy in reproductive-age women using emergency contraception

RATIONALE: Emergency contraception uses drugs or intrauterine devices to prevent pregnancy after unprotected intercourse. Understanding the effectiveness, safety, and acceptability of the various methods available is critical for reproductive healthcare providers and their patien...

Health Care Leaders’ Views About Remotely Delivered Cognitive Behavioral Therapy–Based Services for High-Impact Chronic Pain

Chronic musculoskeletal pain remains a vexing clinical challenge, and health care systems have struggled to identify effective, scalable, and safe treatment alternatives to opioids and other higher-risk interventions. Remotely delivered cognitive behavioral therapy for chronic pa...

Effectiveness of RSV Prevention Strategies in US Infants: 2024–2025

OBJECTIVE: In 2023, 2 products, a long-acting monoclonal antibody (nirsevimab) and maternal respiratory syncytial virus (RSV) vaccination, were recommended in the United States to prevent severe RSV disease among infants in their first RSV season. Low uptake during the 2023 to 20...